Artículos por temáticas

Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease

Guan JZ, Guan WP, Maeda T, Makino N.

Gerontology. 2012;58(1):62-9. doi: 10.1159/000327821. Epub 2011 Sep 7.

Does theatre improve the quality of life of people with dementia?

van Dijk AM, van Weert JC, Dröes RM.

Int Psychogeriatr. 2012 Mar;24(3):367-81. doi: 10.1017/S1041610211001992. Epub 2011 Nov 1.

[Effectivity of early psychosocial counselling for family caregivers in general practioner based dementia care]

Geschke K, Scheurich A, Schermuly I, Laux N, Böttcher A, Fellgiebel A.

Dtsch Med Wochenschr. 2012 Oct;137(43):2201-6. doi: 10.1055/s-0032-1305320. Epub 2012 Oct 17.

Role of ligand-based drug design methodologies toward the discovery of new anti- Alzheimer agents: futures perspectives in Fragment-Based Ligand Design

Speck-Planche A, Luan F, Cordeiro MN.

Curr Med Chem. 2012;19(11):1635-45. doi: 10.2174/092986712799945058.

Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention

Valenzuela M, Esler M, Ritchie K, Brodaty H.

Transl Psychiatry. 2012 Apr 24;2(4):e107. doi: 10.1038/tp.2012.28.

Memantine and functional communication in Alzheimer's disease: results of a 12-week, international, randomized clinical trial

Saxton J, Hofbauer RK, Woodward M, Gilchrist NL, Potocnik F, Hsu HA, Miller ML, Pejović V, Graham SM, Perhach JL.

J Alzheimers Dis. 2012;28(1):109-18. doi: 10.3233/JAD-2011-110947.

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

Winblad B, Andreasen N, Minthon L, Floesser A, Imbert G, Dumortier T, Maguire RP, Blennow K, Lundmark J, Staufenbiel M, Orgogozo JM, Graf A.

Lancet Neurol. 2012 Jul;11(7):597-604. doi: 10.1016/S1474-4422(12)70140-0. Epub 2012 Jun 6.

Continuing donepezil produces cognitive benefits in Alzheimer's

Bland P.

Practitioner. 2012 Apr;256(1750):5.

Life orientation in Finnish family caregivers' of persons with Alzheimer's disease: a diary study

Välimäki T, Vehviläinen-Julkunen K, Pietilä AM, Koivisto A.

Nurs Health Sci. 2012 Dec;14(4):480-7. doi: 10.1111/j.1442-2018.2012.00721.x.

Telephone-based, cognitive-behavioral therapy for African American dementia caregivers with depression: initial findings

Glueckauf RL, Davis WS, Willis F, Sharma D, Gustafson DJ, Hayes J, Stutzman M, Proctor J, Kazmer MM, Murray L, Shipman J, McIntyre V, Wesley L, Schettini G, Xu J, Parfitt F, Graff-Radford N, Baxter C,

Rehabil Psychol. 2012 May;57(2):124-39. doi: 10.1037/a0028688.

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort

Wattmo C, Wallin AK, Minthon L.

BMC Neurol. 2012 Nov 5;12:134. doi: 10.1186/1471-2377-12-134.

Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT

Kimura N, Kumamoto T, Masuda T, Hanaoka T, Okazaki T, Arakawa R.

J Neuroimaging. 2012 Jul;22(3):299-304. doi: 10.1111/j.1552-6569.2011.00612.x. Epub 2011 Jun 23.

Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier

Banks WA.

Adv Drug Deliv Rev. 2012 May 15;64(7):629-39. doi: 10.1016/j.addr.2011.12.005. Epub 2011 Dec 17.

An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ

Adolfsson O, Pihlgren M, Toni N, Varisco Y, Buccarello AL, Antoniello K, Lohmann S, Piorkowska K, Gafner V, Atwal JK, Maloney J, Chen M, Gogineni A, Weimer RM, Mortensen DL, Friesenhahn M, Ho C, Paul

J Neurosci. 2012 Jul 11;32(28):9677-89. doi: 10.1523/JNEUROSCI.4742-11.2012.

[Assessment of benefits of drug therapies: memantine for Alzheimer's disease as an example]

Rüther E, Hellweg R, Janetzky W.

Fortschr Neurol Psychiatr. 2012 Dec;80(12):694-9. doi: 10.1055/s-0032-1312976. Epub 2012 Dec 10.